Top

BMC Cancer

Published in:

Open Access 01-12-2024 | Oral Cancer | Research

Association of DOK3 and infiltrated tumor-associated macrophages with risk for the prognosis of Porphyromonas gingivalis-infected oral cancer: a 12-year data analysis of 200 patients from a tertiary teaching hospital, Urumqi, China

Authors: Chenxi Li, Muqiu Li, Wei Wei, Zhengye Wang, Jingwen Yu, Zhongcheng Gong

Published in: BMC Cancer | Issue 1/2024

Abstract

Background

While there is an understanding of the association between the expression of Porphyromonas gingivalis (P. gingivalis) and prognosis of oral squamous cell carcinoma (OSCC), significance specially to address the relevance between different immunohistochemical intensities of P. gingivalis and tumor-associated macrophages (TAMs) in OSCC tissue and related clinicopathologic characteristics has not been well investigated. The present study aimed to investigate the pathological features related to M2-TAM in P. gingivalis-infected OSCC and ascertain its clinical relevance with patients’ prognosis.

Methods

A prospective cohort study was designed to comparatively analyze 200 patients from June 2008 to June 2020. Bioinformatics analyses were implemented to identify DOK3 as a key molecule and to appraise immunocyte infiltration using Gene Expression Omnibus and The Cancer Genome Atlas databases. Immunohistochemical evaluation was performed to analyze the association between the expression levels of P. gingivalis, DOK3, and M2-TAM and clinicopathological variables using Fisher’s exact test or Pearson’s chi-square test. Cox analysis was used to calculate hazard ratios (HR) with corresponding 95% confidence interval (CI) for various clinicopathological features. The Kaplan–Meier approach and log-rank test were used to plot the survival curves.

Results

The expression level of P. gingivalis was positively associated with DOK3 and M2-TAMs expression level (P < 0.001). Parameters, including body mass index, clinical stage, recurrence, tumor differentiation, and P. gingivalis, DOK3, and M2-TAM immunoexpression levels, affected the prognosis of patients with OSCC (all P < 0.05). In addition, P. gingivalis (HR = 1.674, 95%CI 1.216–4.142, P = 0.012), DOK3 (HR = 1.881, 95%CI 1.433–3.457, P = 0.042), and M2-TAM (HR = 1.649, 95%CI 0.824–3.082, P = 0.034) were significantly associated with the 10-year cumulative survival rate.

Conclusions

Elevated expression of P. gingivalis and DOK3 indicates M2-TAM infiltration and unfavorable prognosis of OSCC, and could be considered as three novel independent risk factors for predicting the prognosis of OSCC.

Available only for authorised users

Li CX, Tan XR, Wei W, Li MQ, Gong ZC. Characteristics and significance of tertiary lymphoid structures in oral cancer. Chin J Stomatol Res. 2023;17(05):315–21. https://doi.org/10.3877/cma.j.issn.1674-1366.2023.05.001.CrossRef

Li CX, Wang ZY, Tong QY, Li MQ, Wei W, Gong ZC. Effect of prognostic factors of postoperative radiotherapy in oral squamous cell carcinoma: A SEER-based study. Ear Nose Throat J. 2023;23:1455613231210388. https://doi.org/10.1177/01455613231210388.CrossRef

Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: Profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584–90. https://doi.org/10.1097/CM9.0000000000002108.CrossRefPubMed

Shrestha AD, Vedsted P, Kallestrup P, Neupane D. Prevalence and incidence of oral cancer in low- and middle-income countries: A scoping review. Eur J Cancer Care (Engl). 2020;29(2):e13207. https://doi.org/10.1111/ecc.13207.CrossRefPubMed

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. https://doi.org/10.3322/caac.21708.CrossRefPubMed

Kim SS, Ruiz VE, Carroll JD, Moss SF. Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett. 2011;305(2):228–38. https://doi.org/10.1016/j.canlet.2010.07.014.CrossRefPubMed

Li CX, Liu H, Gong ZC. What is the potential interplay between microbiome and tumor microenvironment in oral squamous cell carcinomas? Asian Pac J Cancer Prev. 2022;23(7):2199–213. https://doi.org/10.31557/APJCP.2022.23.7.2199.CrossRefPubMedPubMedCentral

Shin YJ, Choung HW, Lee JH, Rhyu IC, Kim HD. Association of periodontitis with oral cancer: A case-control study. J Dent Res. 2019;98(5):526–33. https://doi.org/10.1177/0022034519827565.CrossRefPubMed

Yao QW, Zhou DS, Peng HJ, Ji P, Liu DS. Association of periodontal disease with oral cancer: A meta-analysis. Tumour Biol. 2014;35(7):7073–7. https://doi.org/10.1007/s13277-014-1951-8.CrossRefPubMed

10.

Meyer MS, Joshipura K, Giovannucci E, Michaud DS. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control. 2008;19(9):895–907. https://doi.org/10.1007/s10552-008-9163-4.CrossRefPubMedPubMedCentral

11.

Gao S, Li S, Ma Z, Liang S, Shan T, Zhang M, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer. 2016;11:3. https://doi.org/10.1186/s13027-016-0049-x.CrossRefPubMedPubMedCentral

12.

Chen Q, Shao Z, Liu K, Zhou X, Wang L, Jiang E, et al. Salivary Porphyromonas gingivalis predicts outcome in oral squamous cell carcinomas: a cohort study. BMC Oral Health. 2021;21(1):228. https://doi.org/10.1186/s12903-021-01580-6.CrossRefPubMedPubMedCentral

13.

Guo ZC, Jing SL, Jumatai S, Gong ZC. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment. Cancer Immunol Immunother. 2023;72(6):1523–39. https://doi.org/10.1007/s00262-022-03348-5.CrossRefPubMed

14.

Kawasaki M, Ikeda Y, Ikeda E, Takahashi M, Tanaka D, Nakajima Y, et al. Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer. Cancer. 2021;127(4):512–9. https://doi.org/10.1002/cncr.33316.CrossRefPubMed

15.

Mao S, Park Y, Hasegawa Y, Tribble GD, James CE, Handfield M, et al. Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis. Cell Microbiol. 2007;9(8):1997–2007. https://doi.org/10.1111/j.1462-5822.2007.00931.x.CrossRefPubMedPubMedCentral

16.

Geng F, Liu J, Guo Y, Li C, Wang H, Wang H, et al. Persistent exposure to Porphyromonas gingivalis promotes proliferative and invasion capabilities, and tumorigenic properties of human immortalized oral epithelial cells. Front Cell Infect Microbiol. 2017;7:57. https://doi.org/10.3389/fcimb.2017.00057.CrossRefPubMedPubMedCentral

17.

Petruzzi MN, Cherubini K, Salum FG, de Figueiredo MA. Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge. Diagn Pathol. 2017;12(1):32. https://doi.org/10.1186/s13000-017-0623-6.CrossRefPubMedPubMedCentral

18.

Almangush A, Mäkitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A, et al. Staging and grading of oral squamous cell carcinoma: An update. Oral Oncol. 2020;107:104799. https://doi.org/10.1016/j.oraloncology.2020.104799.CrossRefPubMed

19.

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7. https://doi.org/10.1016/S0140-6736(07)61602-X.CrossRef

20.

Li CX, Su Y, Gong ZC, Liu H. Porphyromonas gingivalis activation of tumor-associated macrophages via DOK3 promotes recurrence of oral squamous cell carcinoma. Med Sci Monit. 2022;28:e937126. https://doi.org/10.12659/MSM.937126.CrossRefPubMedPubMedCentral

21.

Wen L, Mu W, Lu H, Wang X, Fang J, Jia Y, et al. Porphyromonas gingivalis promotes oral squamous cell carcinoma progression in an immune microenvironment. J Dent Res. 2020;99(6):666–75. https://doi.org/10.1177/0022034520909312.CrossRefPubMed

22.

Li C, Chen Q, Tian Z, Li S, Gong Z, Lin Z, et al. Expression of MIF, Beclin1, and LC3 in human salivary gland adenoid cystic carcinoma and its prognostic value. Medicine (Baltimore). 2019;98(20):e15402. https://doi.org/10.1097/MD.0000000000015402.CrossRefPubMed

23.

Gupta B, Bray F, Kumar N, Johnson NW. Associations between oral hygiene habits, diet, tobacco and alcohol and risk of oral cancer: A case-control study from India. Cancer Epidemiol. 2017;51:7–14. https://doi.org/10.1016/j.canep.2017.09.003.CrossRefPubMed

24.

Li CX, Gong ZC, Tan XR. Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma. Cancer Immunol Immunother. 2023;72(9):3133–4. https://doi.org/10.1007/s00262-023-03452-0.CrossRefPubMedPubMedCentral

25.

Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK, et al. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol. 2021;121:105451. https://doi.org/10.1016/j.oraloncology.2021.105451.CrossRefPubMed

26.

Hora SS, Patil SK. Oral microflora in the background of oral cancer: A review. Cureus. 2022;14(12):e33129. https://doi.org/10.7759/cureus.33129.CrossRefPubMedPubMedCentral

27.

Lee J, Roberts JS, Atanasova KR, Chowdhury N, Han K, Yilmaz Ö. Human primary epithelial cells acquire an epithelial-mesenchymal-transition phenotype during long-term infection by the oral opportunistic pathogen, Porphyromonas gingivalis. Front Cell Infect Microbiol. 2017;7:493. https://doi.org/10.3389/fcimb.2017.00493.CrossRefPubMedPubMedCentral

28.

Kong J, Yuan X, Wang J, Liu Y, Sun W, Gu B, et al. Frequencies of Porphyromonas gingivalis detection in oral-digestive tract tumors. Pathol Oncol Res. 2021;27:628942. https://doi.org/10.3389/pore.2021.628942.CrossRefPubMedPubMedCentral

29.

Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis. 2012;33(5):1055–8. https://doi.org/10.1093/carcin/bgs112.CrossRefPubMedPubMedCentral

30.

Benjamin WJ, Wang K, Zarins K, Bellile E, Blostein F, Argirion I, et al. Oral microbiome community composition in head and neck squamous cell carcinoma. Cancers (Basel). 2023;15(9):2549. https://doi.org/10.3390/cancers15092549.CrossRefPubMed

31.

Jiang Y, Brandt BW, Buijs MJ, Cheng L, Exterkate RAM, Crielaard W, et al. Manipulation of saliva-derived microcosm biofilms to resemble dysbiotic subgingival microbiota. Appl Environ Microbiol. 2021;87(3):e02371-e2420. https://doi.org/10.1128/AEM.02371-20.CrossRefPubMedPubMedCentral

32.

Marin MJ, Ambrosio N, Virto L, Diz P, Álvarez M, Herrera D, et al. Detection and quantification of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis and Streptococcus oralis in blood samples with different microbiological identification methods: An in vitro study. Arch Oral Biol. 2017;74:55–62. https://doi.org/10.1016/j.archoralbio.2016.11.007.CrossRefPubMed

33.

Frohwitter G, Zimmermann OL, Kreutzer K, Doll C, Rendenbach CM, Dommisch H, et al. Oxidative and nitrosative stress in oral squamous cell carcinoma. Cells Tissues Organs. 2020;209(2–3):120–7. https://doi.org/10.1159/000508705.CrossRefPubMed

34.

Zhang X, Li S, Malik I, Do MH, Ji L, Chou C, et al. Reprogramming tumour-associated macrophages to outcompete cancer cells. Nature. 2023;619(7970):616–23. https://doi.org/10.1038/s41586-023-06256-5.CrossRefPubMedPubMedCentral

35.

Liu X, Chen F, Li W. Elevated expression of DOK3 indicates high suppressive immune cell infiltration and unfavorable prognosis of gliomas. Int Immunopharmacol. 2020;83:106400. https://doi.org/10.1016/j.intimp.2020.106400.CrossRefPubMed

36.

Modak M, Mattes AK, Reiss D, Skronska-Wasek W, Langlois R, Sabarth N, et al. CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity. JCI Insight. 2022;7(11):e155022. https://doi.org/10.1172/jci.insight.155022.CrossRefPubMedPubMedCentral

37.

Bolz J, Dosá E, Schubert J, Eckert AW. Bacterial colonization of microbial biofilms in oral squamous cell carcinoma. Clin Oral Investig. 2014;18(2):409–14. https://doi.org/10.1007/s00784-013-1007-2.CrossRefPubMed

38.

Subapriya R, Thangavelu A, Mathavan B, Ramachandran CR, Nagini S. Assessment of risk factors for oral squamous cell carcinoma in Chidambaram, Southern India: A case-control study. Eur J Cancer Prev. 2007;16(3):251–6. https://doi.org/10.1097/01.cej.0000228402.53106.9e.CrossRefPubMed

39.

Canick J, Campbell JC, Cohen SM, Jones HN, Leiman DA, Raman S, et al. Preoperative dysphagia risk in community-dwelling adults aged ≥ 50 years: Prevalence and risk factors. Nutr Clin Pract. 2023;38(1):157–66. https://doi.org/10.1002/ncp.10889.CrossRefPubMed

Title: Association of DOK3 and infiltrated tumor-associated macrophages with risk for the prognosis of Porphyromonas gingivalis-infected oral cancer: a 12-year data analysis of 200 patients from a tertiary teaching hospital, Urumqi, China
Authors: Chenxi Li
Muqiu Li
Wei Wei
Zhengye Wang
Jingwen Yu
Zhongcheng Gong
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: Oral Cancer
Oral Cavity Carcinoma
Published in: BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-024-12300-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study

A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR)

The diagnostic potential of miR-196a-1 in colorectal cancer

Prognostic value of pre-treatment [18F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis

Comprehensive analysis of T-cell regulatory factors and tumor immune microenvironment in stomach adenocarcinoma

Development and validation of a novel preoperative clinical model for predicting lymph node metastasis in perihilar cholangiocarcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer